UniProt ID | LACTB_HUMAN | |
---|---|---|
UniProt AC | P83111 | |
Protein Name | Serine beta-lactamase-like protein LACTB, mitochondrial {ECO:0000305} | |
Gene Name | LACTB {ECO:0000312|HGNC:HGNC:16468} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 547 | |
Subcellular Localization | Mitochondrion . | |
Protein Description | Mitochondrial serine protease that acts as a regulator of mitochondrial lipid metabolism. [PubMed: 28329758 Acts by decreasing protein levels of PISD, a mitochondrial enzyme that converts phosphatidylserine (PtdSer) to phosphatidylethanolamine (PtdEtn), thereby affecting mitochondrial lipid metabolism] | |
Protein Sequence | MYRLMSAVTARAAAPGGLASSCGRRGVHQRAGLPPLGHGWVGGLGLGLGLALGVKLAGGLRGAAPAQSPAAPDPEASPLAEPPQEQSLAPWSPQTPAPPCSRCFARAIESSRDLLHRIKDEVGAPGIVVGVSVDGKEVWSEGLGYADVENRVPCKPETVMRIASISKSLTMVALAKLWEAGKLDLDIPVQHYVPEFPEKEYEGEKVSVTTRLLISHLSGIRHYEKDIKKVKEEKAYKALKMMKENVAFEQEKEGKSNEKNDFTKFKTEQENEAKCRNSKPGKKKNDFEQGELYLREKFENSIESLRLFKNDPLFFKPGSQFLYSTFGYTLLAAIVERASGCKYLDYMQKIFHDLDMLTTVQEENEPVIYNRARFYVYNKKKRLVNTPYVDNSYKWAGGGFLSTVGDLLKFGNAMLYGYQVGLFKNSNENLLPGYLKPETMVMMWTPVPNTEMSWDKEGKYAMAWGVVERKQTYGSCRKQRHYASHTGGAVGASSVLLVLPEELDTETINNKVPPRGIIVSIICNMQSVGLNSTALKIALEFDKDRSD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MYRLMSAVT ------CCHHHHHHH | 16.68 | 24043423 | |
6 | Phosphorylation | --MYRLMSAVTARAA --CCHHHHHHHHHHC | 24.95 | 20068231 | |
9 | Phosphorylation | YRLMSAVTARAAAPG CHHHHHHHHHHCCCC | 15.33 | 28258704 | |
20 | Phosphorylation | AAPGGLASSCGRRGV CCCCCCHHHCCCCCH | 31.07 | 24670416 | |
21 | Phosphorylation | APGGLASSCGRRGVH CCCCCHHHCCCCCHH | 18.25 | 24670416 | |
140 | Phosphorylation | VDGKEVWSEGLGYAD ECCHHHHCCCCCCCC | 27.28 | - | |
164 | Phosphorylation | ETVMRIASISKSLTM HHHHHHHHHCHHHHH | 25.64 | 19764811 | |
166 | Phosphorylation | VMRIASISKSLTMVA HHHHHHHCHHHHHHH | 17.44 | 24641631 | |
168 | Phosphorylation | RIASISKSLTMVALA HHHHHCHHHHHHHHH | 23.45 | 20860994 | |
170 | Phosphorylation | ASISKSLTMVALAKL HHHCHHHHHHHHHHH | 19.38 | 20860994 | |
182 | Ubiquitination | AKLWEAGKLDLDIPV HHHHHCCCCCCCCCH | 45.97 | 29967540 | |
199 | Ubiquitination | YVPEFPEKEYEGEKV HCCCCCCHHCCCCEE | 66.87 | 29967540 | |
201 | Phosphorylation | PEFPEKEYEGEKVSV CCCCCHHCCCCEEEH | 40.06 | - | |
205 | 2-Hydroxyisobutyrylation | EKEYEGEKVSVTTRL CHHCCCCEEEHHHHH | 51.14 | - | |
205 | Ubiquitination | EKEYEGEKVSVTTRL CHHCCCCEEEHHHHH | 51.14 | 33845483 | |
207 | Phosphorylation | EYEGEKVSVTTRLLI HCCCCEEEHHHHHHH | 25.47 | 26437602 | |
215 | Phosphorylation | VTTRLLISHLSGIRH HHHHHHHHHHHCCCH | 20.53 | 20068231 | |
218 | Phosphorylation | RLLISHLSGIRHYEK HHHHHHHHCCCHHHH | 27.10 | 24719451 | |
225 | 2-Hydroxyisobutyrylation | SGIRHYEKDIKKVKE HCCCHHHHHHHHHHH | 58.55 | - | |
228 | Acetylation | RHYEKDIKKVKEEKA CHHHHHHHHHHHHHH | 62.74 | 2380299 | |
234 | 2-Hydroxyisobutyrylation | IKKVKEEKAYKALKM HHHHHHHHHHHHHHH | 59.10 | - | |
236 | Phosphorylation | KVKEEKAYKALKMMK HHHHHHHHHHHHHHH | 14.09 | 30631047 | |
237 | Trimethylation | VKEEKAYKALKMMKE HHHHHHHHHHHHHHH | 52.69 | - | |
237 | Acetylation | VKEEKAYKALKMMKE HHHHHHHHHHHHHHH | 52.69 | 7970937 | |
237 | Methylation | VKEEKAYKALKMMKE HHHHHHHHHHHHHHH | 52.69 | - | |
243 | 2-Hydroxyisobutyrylation | YKALKMMKENVAFEQ HHHHHHHHHHCCCHH | 42.51 | - | |
243 | Malonylation | YKALKMMKENVAFEQ HHHHHHHHHHCCCHH | 42.51 | 26320211 | |
243 | Succinylation | YKALKMMKENVAFEQ HHHHHHHHHHCCCHH | 42.51 | 27452117 | |
243 | Acetylation | YKALKMMKENVAFEQ HHHHHHHHHHCCCHH | 42.51 | 25825284 | |
252 | Malonylation | NVAFEQEKEGKSNEK HCCCHHHHCCCCCCC | 72.03 | 26320211 | |
252 | Succinylation | NVAFEQEKEGKSNEK HCCCHHHHCCCCCCC | 72.03 | 27452117 | |
252 | Acetylation | NVAFEQEKEGKSNEK HCCCHHHHCCCCCCC | 72.03 | 25953088 | |
259 | Succinylation | KEGKSNEKNDFTKFK HCCCCCCCCCCCCHH | 67.10 | 23954790 | |
259 | Acetylation | KEGKSNEKNDFTKFK HCCCCCCCCCCCCHH | 67.10 | 23749302 | |
264 | Malonylation | NEKNDFTKFKTEQEN CCCCCCCCHHHHHHH | 44.87 | 26320211 | |
264 | Acetylation | NEKNDFTKFKTEQEN CCCCCCCCHHHHHHH | 44.87 | 19608861 | |
266 | Succinylation | KNDFTKFKTEQENEA CCCCCCHHHHHHHHH | 53.35 | 27452117 | |
266 | Acetylation | KNDFTKFKTEQENEA CCCCCCHHHHHHHHH | 53.35 | 26051181 | |
266 | Malonylation | KNDFTKFKTEQENEA CCCCCCHHHHHHHHH | 53.35 | 26320211 | |
274 | Succinylation | TEQENEAKCRNSKPG HHHHHHHHHCCCCCC | 27.78 | 27452117 | |
279 | Ubiquitination | EAKCRNSKPGKKKND HHHHCCCCCCCCCCC | 62.43 | 24816145 | |
283 | Malonylation | RNSKPGKKKNDFEQG CCCCCCCCCCCHHHC | 63.82 | 26320211 | |
283 | Succinylation | RNSKPGKKKNDFEQG CCCCCCCCCCCHHHC | 63.82 | - | |
283 | Succinylation | RNSKPGKKKNDFEQG CCCCCCCCCCCHHHC | 63.82 | 27452117 | |
284 | Succinylation | NSKPGKKKNDFEQGE CCCCCCCCCCHHHCC | 66.30 | - | |
284 | Succinylation | NSKPGKKKNDFEQGE CCCCCCCCCCHHHCC | 66.30 | 27452117 | |
284 | Ubiquitination | NSKPGKKKNDFEQGE CCCCCCCCCCHHHCC | 66.30 | 29967540 | |
284 | Malonylation | NSKPGKKKNDFEQGE CCCCCCCCCCHHHCC | 66.30 | 26320211 | |
297 | 2-Hydroxyisobutyrylation | GELYLREKFENSIES CCCHHHHHHHCHHHH | 52.09 | - | |
297 | Acetylation | GELYLREKFENSIES CCCHHHHHHHCHHHH | 52.09 | 23236377 | |
297 | Ubiquitination | GELYLREKFENSIES CCCHHHHHHHCHHHH | 52.09 | 24816145 | |
297 | Malonylation | GELYLREKFENSIES CCCHHHHHHHCHHHH | 52.09 | 26320211 | |
342 | Acetylation | VERASGCKYLDYMQK HHHHCCCCHHHHHHH | 52.99 | 19608861 | |
342 | Malonylation | VERASGCKYLDYMQK HHHHCCCCHHHHHHH | 52.99 | 26320211 | |
343 | Phosphorylation | ERASGCKYLDYMQKI HHHCCCCHHHHHHHH | 14.64 | - | |
346 | Phosphorylation | SGCKYLDYMQKIFHD CCCCHHHHHHHHHHC | 10.00 | - | |
377 | Phosphorylation | NRARFYVYNKKKRLV ECCEEEEEECCCCCC | 15.19 | - | |
379 | Malonylation | ARFYVYNKKKRLVNT CEEEEEECCCCCCCC | 41.82 | 26320211 | |
379 | 2-Hydroxyisobutyrylation | ARFYVYNKKKRLVNT CEEEEEECCCCCCCC | 41.82 | - | |
379 | Acetylation | ARFYVYNKKKRLVNT CEEEEEECCCCCCCC | 41.82 | 19608861 | |
380 | Acetylation | RFYVYNKKKRLVNTP EEEEEECCCCCCCCC | 39.22 | 6570433 | |
388 | Phosphorylation | KRLVNTPYVDNSYKW CCCCCCCCCCCCCCC | 20.56 | 20068231 | |
392 | Phosphorylation | NTPYVDNSYKWAGGG CCCCCCCCCCCCCCC | 24.51 | 20068231 | |
392 | O-linked_Glycosylation | NTPYVDNSYKWAGGG CCCCCCCCCCCCCCC | 24.51 | 28510447 | |
393 | Phosphorylation | TPYVDNSYKWAGGGF CCCCCCCCCCCCCCH | 19.46 | 20068231 | |
418 | Phosphorylation | GNAMLYGYQVGLFKN CCEEECCEEEEEECC | 6.10 | 20860994 | |
473 | Phosphorylation | VVERKQTYGSCRKQR EEECCCCCCCHHCCH | 12.44 | - | |
475 | Phosphorylation | ERKQTYGSCRKQRHY ECCCCCCCHHCCHHH | 10.59 | - | |
532 | Phosphorylation | MQSVGLNSTALKIAL CCCCCCCHHHHHHHH | 21.79 | 20833797 | |
543 | Ubiquitination | KIALEFDKDRSD--- HHHHHCCCCCCC--- | 61.43 | 29967540 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of LACTB_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LACTB_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LACTB_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
LACTB_HUMAN | LACTB | physical | 27499296 | |
NDKM_HUMAN | NME4 | physical | 27499296 | |
ECH1_HUMAN | ECH1 | physical | 27499296 | |
PDIP2_HUMAN | POLDIP2 | physical | 27499296 | |
PREP_HUMAN | PITRM1 | physical | 27499296 | |
C1QBP_HUMAN | C1QBP | physical | 27499296 | |
C102A_HUMAN | CCDC102A | physical | 28514442 | |
COPRS_HUMAN | COPRS | physical | 28514442 | |
RIOK1_HUMAN | RIOK1 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-264 AND LYS-342, AND MASSSPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6, AND MASSSPECTROMETRY. |